Infusion with paracetamol — Competitive Intelligence Brief

Infusion with paracetamol (Infusion with paracetamol) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Analgesic and antipyretic. Area: Pain management, Fever reduction.

marketed Analgesic and antipyretic Cyclooxygenase (COX) enzymes Pain management, Fever reduction Small molecule

Target snapshot

Infusion with paracetamol (Infusion with paracetamol) — University of Helsinki. Paracetamol inhibits prostaglandin synthesis in the central nervous system to reduce pain and fever.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Infusion with paracetamol TARGET	Infusion with paracetamol	University of Helsinki	marketed	Analgesic and antipyretic	Cyclooxygenase (COX) enzymes
Acetaminophen/APAP	Acetaminophen/APAP	John van den Anker	marketed	Analgesic and antipyretic	Cyclooxygenase (COX), primarily central nervous system isoforms
IV Acetaminophen (Treatment A)	IV Acetaminophen (Treatment A)	Mallinckrodt	marketed	Analgesic and antipyretic	Cyclooxygenase (COX) enzymes
Panadol®	Panadol®	Sinew Pharma Inc.	marketed	Analgesic and antipyretic (non-NSAID)	Cyclooxygenase (COX), primarily in central nervous system
Tylenol Pill	Tylenol Pill	Shanghai Zhongshan Hospital	marketed	Analgesic and antipyretic	Cyclooxygenase (COX), primarily central nervous system isoforms
Preop acetaminophen IV	Preop acetaminophen IV	AdventHealth	marketed	Analgesic and antipyretic (non-NSAID)	Cyclooxygenase (COX) enzymes
IV Acetaminophen	IV Acetaminophen	Mallinckrodt	marketed	Analgesic and antipyretic	Cyclooxygenase (COX) enzymes

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Analgesic and antipyretic class)

1. Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina · 2 drugs in this class
2. Mallinckrodt · 2 drugs in this class
3. The University of Texas Health Science Center, Houston · 2 drugs in this class
4. Hellenic Society of Hematology · 1 drug in this class
5. John van den Anker · 1 drug in this class
6. Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division · 1 drug in this class
7. Maoxiang Group Jilin Pharmaceutical Co., Ltd. · 1 drug in this class
8. Merck Sharp & Dohme LLC · 1 drug in this class
9. Mount Sinai Hospital, Canada · 1 drug in this class
10. Nantes University Hospital · 1 drug in this class